Page 1 | Search Results | Molecular Cancer Therapeutics | American Association for Cancer Research

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Pretargeted Anti-CD20 Radioimmunotherapy with scFv Fusion Protein Safely Combines with BEAM and ASCT in patients with High-Risk B-cell Lymphomas

Johnnie J. Orozco, Manuela C. Matesan, Sally J. Lundberg, Robyn L. Haaf, Robert S. Miyaoka, Darrell R. Fisher, Ted A. Gooley, Damian J. Green, Brenda M. Sandmaier, Paul S. Martin, Ajay K. Gopal

Mol Cancer Ther (2025)

https://doi.org/10.1158/1535-7163.MCT-24-0550

Published: 03 July 2025

View articletitled, Pretargeted Anti-CD20 Radioimmunotherapy with scFv Fusion Protein Safely Combines with BEAM and ASCT in patients with High-Risk B-cell Lymphomas

Includes: Supplementary data

Journal Articles

Development of a Novel Bifunctional Anti-CD47 Fusion Protein with Improved Efficacy and a Favorable Safety Profile

Sittana Matar, Seham Skah, Liza E. Diomande, Tim Buss, Hanne R. Hagland, Ajay Yadav, Rune J. Forstrøm, Bjørn Dalhus, Kjetil Hestdal, Rolf D. Pettersen, Nina Richartz

Mol Cancer Ther (2025) 24 (6): 816–827.

https://doi.org/10.1158/1535-7163.MCT-24-0917

Published: 04 June 2025

View articletitled, Development of a Novel Bifunctional Anti-CD47 Fusion Protein with Improved Efficacy and a Favorable Safety Profile

Includes: Supplementary data

Journal Articles

Abstract A015: Exploiting endogenous replication stress with a novel targeted therapy in Ewing sarcoma

Emily Isenhart, Ajay Gupta, Bryan Gillard, Kristopher Attwood, Joyce Ohm

Mol Cancer Ther (2024) 23 (6_Supplement): A015.

https://doi.org/10.1158/1538-8514.SYNTHLETH24-A015

Published: 10 June 2024

View articletitled, Abstract A015: Exploiting endogenous replication stress with a novel targeted therapy in Ewing sarcoma

Journal Articles

Porcupine Inhibition Disrupts Mitochondrial Function and Homeostasis in WNT Ligand–Addicted Pancreatic Cancer

Kristina Y. Aguilera, Thuc Le, Rana Riahi, Anna R. Lay, Stefan Hinz, Edris A. Saadat, Ajay A. Vashisht, James Wohlschlegel, Timothy R. Donahue, Caius G. Radu, David W. Dawson

Mol Cancer Ther (2022) 21 (6): 936–947.

https://doi.org/10.1158/1535-7163.MCT-21-0623

Published: 01 June 2022

View articletitled, Porcupine Inhibition Disrupts Mitochondrial Function and Homeostasis in WNT Ligand–Addicted Pancreatic Cancer

Includes: Supplementary data

Journal Articles

Therapy of Myeloid Leukemia using Novel Bispecific Fusion Proteins Targeting CD45 and ⁹⁰Y-DOTA

Mol Cancer Ther (2020) 19 (12): 2575–2584.

https://doi.org/10.1158/1535-7163.MCT-20-0306

Published: 02 December 2020

View articletitled, Therapy of Myeloid Leukemia using Novel Bispecific Fusion Proteins Targeting CD45 and 90Y-DOTA

Includes: Supplementary data

Journal Articles

TGFβ Blockade Augments PD-1 Inhibition to Promote T-Cell–Mediated Regression of Pancreatic Cancer

Daniel R. Principe, Alex Park, Matthew J. Dorman, Sandeep Kumar, Navin Viswakarma, Jonathan Rubin, Carolina Torres, Ronald McKinney, Hidayatullah G. Munshi, Paul J. Grippo, Ajay Rana

Mol Cancer Ther (2019) 18 (3): 613–620.

https://doi.org/10.1158/1535-7163.MCT-18-0850

Published: 01 March 2019

View articletitled, TGFβ Blockade Augments PD-1 Inhibition to Promote T-Cell–Mediated Regression of Pancreatic Cancer

Includes: Supplementary data

Journal Articles

Abstract PL06-04: Molecular characterization of circulating tumor cells.

Daniel A. Haber, Shyamala Maheswaran, Lecia Sequist, Min Yu, Emre Ozkumur, David Ting, David Miyamoto, Richard Lee, Ajay Shah, Aditya Bardia, Shannon Stott, Mehmet Toner

Mol Cancer Ther (2013) 12 (11_Supplement): PL06-04.

https://doi.org/10.1158/1535-7163.TARG-13-PL06-04

Published: 01 November 2013

View articletitled, Abstract PL06-04: Molecular characterization of circulating tumor cells.

Journal Articles

Modulation of Protein Phosphatase 2A Activity Alters Androgen-Independent Growth of Prostate Cancer Cells: Therapeutic Implications

Arun Bhardwaj, Seema Singh, Sanjeev K. Srivastava, Richard E. Honkanen, Eddie Reed, Ajay P. Singh

Mol Cancer Ther (2011) 10 (5): 720–731.

https://doi.org/10.1158/1535-7163.MCT-10-1096

Published: 08 May 2011

View articletitled, Modulation of Protein Phosphatase 2A Activity Alters Androgen-Independent Growth of Prostate Cancer Cells: Therapeutic Implications

Journal Articles

Small Interfering RNA Targeting 14-3-3ζ Increases Efficacy of Chemotherapeutic Agents in Head and Neck Cancer Cells

Ajay Matta, Leroi V. DeSouza, Ranju Ralhan, K.W. Michael Siu

Mol Cancer Ther (2010) 9 (10): 2676–2688.

https://doi.org/10.1158/1535-7163.MCT-10-0312

Published: 10 October 2010

View articletitled, Small Interfering RNA Targeting 14-3-3ζ Increases Efficacy of Chemotherapeutic Agents in Head and Neck Cancer Cells

Includes: Supplementary data

Journal Articles

Tumor refractoriness to anti-VEGF treatment mediated by CD11b+Gr1+ myeloid cells

Farbod Shojaei, Xiumin Wu, Ajay Malik, Cuiling Zhong, Megan Baldwin, Stefanie Schanz, Germaine Fuh, Hans-Peter Gerber, Napoleone Ferrara

Mol Cancer Ther (2007) 6 (11_Supplement): A34.

Published: 01 November 2007

View articletitled, Tumor refractoriness to anti-VEGF treatment mediated by CD11b+Gr1+ myeloid cells

Journal Articles

Activity of a novel HDAC inhibitor PCI-24781 in colorectal cancer: Discovery and validation of biomarkers of sensitivity and resistance

Sriram Balasubramanian, Shanthi Adimoolam, P Ajay, Steve Capaldi, Noel Southall, Dewi Ngadimo, Hannah Mamuszka, William Ricketts, Joseph Buggy

Mol Cancer Ther (2007) 6 (11_Supplement): C234.

Published: 01 November 2007

View articletitled, Activity of a novel HDAC inhibitor PCI-24781 in colorectal cancer: Discovery and validation of biomarkers of sensitivity and resistance

Journal Articles

OB-24, a novel selective and potent HO-1 inhibitor, induces a wide spectrum anti-tumor activity in vitro and in vivo and synergizes with chemotherapy drugs

Moulay. Alaoui-Jamali, Walter Szarek, Kenji Nakatsu, Jason Vlahakis, Ajay Gupta, Hyman Schipper

Mol Cancer Ther (2007) 6 (11_Supplement): C82.

Published: 01 November 2007

View articletitled, OB-24, a novel selective and potent HO-1 inhibitor, induces a wide spectrum anti-tumor activity in vitro and in vivo and synergizes with chemotherapy drugs

Journal Articles

Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panel

Mol Cancer Ther (2006) 5 (4): 853–867.

https://doi.org/10.1158/1535-7163.MCT-05-0155

Published: 28 April 2006

View articletitled, Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panel

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Pretargeted Anti-CD20 Radioimmunotherapy with scFv Fusion Protein Safely Combines with BEAM and ASCT in patients with High-Risk B-cell Lymphomas

Development of a Novel Bifunctional Anti-CD47 Fusion Protein with Improved Efficacy and a Favorable Safety Profile

Abstract A015: Exploiting endogenous replication stress with a novel targeted therapy in Ewing sarcoma

Porcupine Inhibition Disrupts Mitochondrial Function and Homeostasis in WNT Ligand–Addicted Pancreatic Cancer

Therapy of Myeloid Leukemia using Novel Bispecific Fusion Proteins Targeting CD45 and ⁹⁰Y-DOTA

TGFβ Blockade Augments PD-1 Inhibition to Promote T-Cell–Mediated Regression of Pancreatic Cancer

Abstract PL06-04: Molecular characterization of circulating tumor cells.

Modulation of Protein Phosphatase 2A Activity Alters Androgen-Independent Growth of Prostate Cancer Cells: Therapeutic Implications

Small Interfering RNA Targeting 14-3-3ζ Increases Efficacy of Chemotherapeutic Agents in Head and Neck Cancer Cells

Tumor refractoriness to anti-VEGF treatment mediated by CD11b+Gr1+ myeloid cells

Activity of a novel HDAC inhibitor PCI-24781 in colorectal cancer: Discovery and validation of biomarkers of sensitivity and resistance

OB-24, a novel selective and potent HO-1 inhibitor, induces a wide spectrum anti-tumor activity in vitro and in vivo and synergizes with chemotherapy drugs

Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panel

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only